La catena delle opzioni mostra i dati chiave delle opzioni azionarie di eHealth a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per eHealth..

eHealth (NASDAQ:EHTH) Azioni, Catena delle Opzioni

eHealth

eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.

eHealth Inc

eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) sees FY2025 sales of $510.000 million-$550.000 million vs $528.54 million analyst estimate.

News

Guidance

EHTH

eHealth Sees FY2025 Sales $510.000M-$550.000M vs $528.54M Est

eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) reported quarterly earnings of $2.51 per share which beat the analyst consensus estimate of $2.06 by 21.84 percent. This is a 97.64 percent increase over earnings of $1.27 per share from the same period last year. The company reported quarterly sales of $315.18 million which beat the analyst consensus estimate of $284.11 million by 10.94 percent. This is a 27.26 percent increase over sales of $247.66 million the same period last year.

Earnings

Earnings Beats

eHealth Q4 EPS $2.51 Beats $2.06 Estimate, Sales $315.18M Beat $284.11M Estimate

AAOI

ABEV

ACAD

ACMR

ADTN

ALEC

AMBA

AMBC

AMSF

ARDT

ARHS

ARIS

ARKO

ASTE

ATEC

AVDX

AVNS

BATRA

BATRK

BBSI

BLMN

BXSL

BYND

CAPL

CDNA

CERT

CLDT

CLPT

COCO

COMM

CORT

Core Scientific, Inc. - Class A Common Stock

CORZ

CPRX

CRGY

CSAN

CTRI

DHIL

DMRC

DOLE

DORM

EBAY

ECPG

ENIC

ENOV

ERII

ESCA

ESTA

EVTC

FTAI

FWRD

GERN

GOGL

GSX Techedu Inc. American Depositary Shares

GOTU

GRBK

HCAT

HNST

IBTA

IMCR

Earnings Scheduled For February 26, 2025

<h3>Gainers</h3>
<ul>
<li>XChange Tec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XHG#NASDAQ">XHG</a>) stock increased by 27.4% to $1.44 during Monday's pre-market session. The market value of their outstanding shares is at $162.1 million. </li>
<li>Stock Yards Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYBT#NASDAQ">SYBT</a>) stock moved upwards by 27.07% to $84.62. The market value of their outstanding shares is at $2.4 billion. </li>
<li>S&amp;T Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STBA#NASDAQ">STBA</a>) shares increased by 26.07% to $44.67. The market value of their outstanding shares is at $1.7 billion. </li>
<li>Hamilton Lane (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLNE#NASDAQ">HLNE</a>) stock moved upwards by 12.46% to $157.18. The market value of their outstanding shares is at $6.5 billion. </li>
<li>Powell Max (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMAX#NASDAQ">PMAX</a>) shares moved upwards by 9.72% to $2.03. The market value of their outstanding shares is at $29.8 million. </li>
<li>Greenpro Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRNQ#NASDAQ">GRNQ</a>) stock increased by 9.52% to $2.07. The company's market cap stands at $15.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>FirstCash Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCFS#NASDAQ">FCFS</a>) shares declined by 29.6% to $75.08 during Monday's pre-market session. The company's market cap stands at $3.3 billion. </li>
<li>RenaissanceRe Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNR#NYSE">RNR</a>) shares declined by 11.29% to $221.83. The market value of their outstanding shares is at $11.5 billion. </li>
<li>ProAssurance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) stock decreased by 9.98% to $12.81. The company's market cap stands at $655.3 million. </li>
<li>Vinci Partners Inv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VINP#NASDAQ">VINP</a>) shares fell 8.5% to $8.51. The company's market cap stands at $549.9 million. </li>
<li>Hennessy Advisors (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HNNA#NASDAQ">HNNA</a>) stock decreased by 8.39% to $10.6. The market value of their outstanding shares is at $82.4 million. </li>
<li>eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) shares fell 8.33% to $9.03. The company's market cap stands at $267.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-financial-services-stocks/" title="www.benzinga.com/money/best-financial-services-stocks/">www.benzinga.com/money/best-financial-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

FCFS

GRNQ

HLNE

HNNA

PMAX

STBA

SYBT

VINP

12 Financials Stocks Moving In Monday's Pre-Market Session

WIIM

eHealth shares are trading higher after the company raised its full-year revenue outlook and adjusted EBITDA guidance.

eHealth Raises Full-Year Revenue Outlook From $470M-$495M to $500M-$520M vs $487.43M Est.; Raises Adjusted EBITDA Outlook From $7.5M-$25M to $40M-$55M

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Alliance Global Partners analyst Brian Kinstlinger initiated coverage on Bitfarms Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BITF#NASDAQ">BITF</a>) with a Buy rating and announced a price target of $6. Bitfarms shares closed at $1.99 on Tuesday. <a href="https://www.benzinga.com/quote/KR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS analyst Jonathan Yong initiated coverage on eHealth, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) with a Neutral rating and announced a price target of $5.5. eHealth shares closed at $5.67 on Tuesday. <a href="https://www.benzinga.com/quote/PNW/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Mizuho analyst Steven Valiquette initiated coverage on Veeva Systems Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) with an Outperform rating and announced a price target of $275. Veeva Systems shares closed at $226.46 on Tuesday. <a href="https://www.benzinga.com/quote/KR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst George Notter initiated coverage on Coherent Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) with a Buy rating and announced a price target of $135. Coherent shares closed at $106.54 on Tuesday. <a href="https://www.benzinga.com/quote/KR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JMP Securities analyst Jason Butler initiated coverage on ABIVAX Société Anonyme (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABVX#NASDAQ">ABVX</a>) with a Market Outperform rating and announced a price target of $33. Abivax shares closed at $8.30 on Tuesday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying VEEV stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="584" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04081129/image-35-1024x584.png" alt="" class="wp-image-676364" style="width:635px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04081129/image-35-1024x584.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04081129/image-35-300x171.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04081129/image-35-768x438.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04081129/image-35.png 1097w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42293707/jim-cramer-prefers-this-delivery-giant-over-ups">Jim Cramer Prefers FedEx Over This Delivery Giant That &#8216;Screwed Up A Lot Of Holiday Seasons&#8217;</a></li>
</ul>

Initiation

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

ABVX

BITF

COHR

VEEV

This Veeva Systems Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

UBS analyst Jonathan Yong initiates coverage on eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) with a Neutral rating and announces Price Target of $5.5.

Price Target

UBS Initiates Coverage On eHealth with Neutral Rating, Announces Price Target of $5.5

RBC Capital analyst Frank Morgan maintains eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) with a Sector Perform and lowers the price target from $13 to $11.

RBC Capital Maintains Sector Perform on eHealth, Lowers Price Target to $11

Craig-Hallum analyst George Sutton upgrades eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) from Hold to Buy and raises the price target from $5 to $7.

Upgrades

Craig-Hallum Upgrades eHealth to Buy, Raises Price Target to $7

EHealth shares are trading lower after the company reported worse-than-expected Q3 financial results.

eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) reported quarterly losses of $(1.47) per share which missed the analyst consensus estimate of $(1.28) by 14.84 percent. The company reported quarterly sales of $58.409 million which missed the analyst consensus estimate of $58.557 million by 0.25 percent. This is a 9.75 percent decrease over sales of $64.718 million the same period last year.

Earnings Misses

eHealth Q3 2024 Adj. EPS $(1.47) Misses $(1.28) Estimate, Sales $58.409M Miss $58.557M Estimate

eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) affirms FY2024 sales outlook from $470.00 million-495.00 million to $470.00 million-495.00 million.

eHealth Affirms FY2024 Sales Guidance to $470.00M-495.00M  VS Est. 483.54M

eHealth Secures HITRUST i1 Certification For Carrier Integration Platform, Reinforcing Commitment To Data Protection And Cybersecurity In Healthcare

CLOV

ELEV

GOCO

Biden-Harris Administration Proposes Medicare $2 Drug List Model To Lower Prescription Costs; CMS Seeks Feedback On Sample Drug List And Outreach With Voluntary Participation For Part D Sponsors Starting As Early As Jan 2027; Model To Include Drugs For Common Conditions With Periodic Updates Based On New Generics, Clinical Indications, And Pricing Trends

Deutsche Bank analyst George Hill maintains eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) with a Hold and lowers the price target from $5 to $2.

Deutsche Bank Maintains Hold on eHealth, Lowers Price Target to $2

Craig-Hallum analyst George Sutton maintains eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) with a Hold and lowers the price target from $6 to $5.

Craig-Hallum Maintains Hold on eHealth, Lowers Price Target to $5

eHealth shares are trading lower, reversing after earlier rising on better-than-expected Q2 financial results.

General

eHealth shares are trading higher after the company reported better-than-expected Q2 sales results and issued FY24 revenue guidance above estimates.

eHealth Sees FY24 Revenue $470M-$495M Vs $466.574M Est.

Press Releases

Facing Increased Costs, 64% of Medicare Beneficiaries Express Higher Confidence in the Future of Medicare Under a Trump Administration

eHealth, Inc. Updates Guidance for Fiscal Year 2024 Following Strong AEP Performance

eHealth, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

"Iris by eHealth" ICHRA Solution Makes Employer Health Benefits Affordable with Personalized Coverage for Employees

eHealth, Inc. to Hold Fourth Quarter and Fiscal Year 2024 Earnings Call on February 26 at 8:30 a.m. Eastern Time

Modivcare Announces Changes to Board of Directors

Management

Fortrea to Add Erin L. Russell to Board of Directors

eHealth, Inc. Announces Fourth Quarter and Fiscal Year 2024 Results

New eHealth Research Finds Americans are Unhappy with the US Healthcare System and Open to New Ideas

eHealth, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

FTRE

MODV

SVACU

TVTY

Abacus Global Management, Inc. - Class A Common Stock

Abacus Global Management

Arthur J. Gallagher

Aon plc Class A Ordinary Shares (Ireland)

Brown & Brown

The Baldwin Insurance Group, Inc. - Class A Common Stock

Baldwin Insurance

Cheche Group Inc. - Class A Ordinary Shares

Cheche Group

Crawford & Company Common Stock

GoHealth

Goosehead Insurance, Inc. - Class A Common Stock

Goosehead Insurance

Hagerty

Hippo Holdings

Health In Tech, Inc. - Class A Common Stock

Health In Tech

Huize Holding Limited - American Depositary Shares

Huize Holding

Marsh & McLennan Companies, Inc. Common Stock

Marsh & McLennan Cos

Reliance Global Group, Inc. - Common Stock

Reliance Global Group

Ryan Specialty Holdings, Inc. Class A Common Stock

Ryan Specialty Hldgs

SelectQuote

TIAN RUIXIANG Holdings Ltd - Class A Ordinary Shares

Tian Ruixiang Holdings

TWFG

Waterdrop Inc. American Depositary Shares (each representing the right to receive 10 Class A Ordinary Shares)

Comments

eHealth

eHealth (EHTH) Opzioni

eHealth (NASDAQ:EHTH) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO